RNTECH and DNAVision announce a co-marketing agreement to offer complete solution for biomarker and target discovery
01-Feb-2006
The RNTECH/DNAVision offer associates these key components, creating a opportunity for pharmaceutical and biotechnology industries to access discovery and development expertise in oncology for biomarker and drugable target discovery and development.
Most read news
Topics
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.